Art. 10 Regulation (EU) 2016/161

Verification of the safety features

In forcesince 2 Oct 2015cited 4×

When verifying the safety features, manufacturers, wholesalers and persons authorised or entitled to supply medicinal products to the public shall verify the following:

(a)

the authenticity of the unique identifier;

(b)

the integrity of the anti-tampering device.

  • Opinion of Advocate General Szpunar delivered on 13 January 2022. Novartis Pharma GmbH v Abacus Medicine A/S.Decision

    Such resistance may exist, in particular, to the packaging of medicinal products whose anti-tampering devices have been replaced. That is particularly so since Articles 10, 24 and 30 of Delegated Regulation 2016/161 place on wholesalers …

    13 Jan 2022 · 62020CC0147

  • Judgment of the Court (Fifth Chamber) of 17 November 2022. Merck Sharp & Dohme BV and Others v Abacus Medicine A/S and Others.Decision

    Article 10 of that delegated regulation, entitled ‘Verification of the safety features’, is worded as follows: ‘When verifying the safety features, manufacturers, wholesalers and persons authorised or entitled to supply medicinal …

    17 Nov 2022 · 62020CJ0224

  • Judgment of the Court (Fifth Chamber) of 17 November 2022. Bayer Intellectual Property GmbH v kohlpharma GmbH.Decision

    Article 10 of Delegated Regulation 2016/161, entitled ‘Verification of the safety features’, is worded as follows: ‘When verifying the safety features, manufacturers, wholesalers and persons authorised or entitled to supply medicinal …

    17 Nov 2022 · 62020CJ0204

  • Judgment of the Court (Fifth Chamber) of 17 November 2022. Novartis Pharma GmbH v Abacus Medicine A/S.Decision

    Article 10 of Delegated Regulation 2016/161, entitled ‘Verification of the safety features’, is worded as follows: ‘When verifying the safety features, manufacturers, wholesalers and persons authorised or entitled to supply medicinal …

    17 Nov 2022 · 62020CJ0147